US stock insider trading | Schrodinger disclosed 8 insider transactions on March 6

robot
Abstract generation in progress

On March 6, 2026, Schrödinger (SDGR) disclosed eight insider trading transactions. Director Farid Ramy sold 3,661 shares on that day.

【Recent Insider Transactions】

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
March 6, 2026 Executive Akinsanya Karen March 5, 2026 Sell 1,366 12.90 $17.6k
March 6, 2026 Executive Abel Robert Lorne March 4, 2026 Sell 1,300 12.81 $16.7k
March 6, 2026 Executive Tran Yvonne March 5, 2026 Sell 1,094 12.90 $14.1k
March 6, 2026 Executive Lorton Kenneth Patrick March 5, 2026 Sell 1,222 12.90 $15.8k
March 6, 2026 Director Farid Ramy March 5, 2026 Sell 3,661 12.91 $47.2k
March 6, 2026 Executive Herman Jenny March 6, 2026 Sell 608 12.84 $7,808
March 6, 2026 Executive Herman Jenny March 5, 2026 Sell 775 12.85 $9,956
March 6, 2026 Executive Jain Rachit March 5, 2026 Sell 1,631 12.90 $21k
March 3, 2026 Director Farid Ramy March 2, 2026 Sell 5,560 11.90 $66.2k
March 3, 2026 Executive Akinsanya Karen March 2, 2026 Sell 2,206 11.99 $26.5k

【Company Profile】

Schrödinger, Inc. was incorporated in California in August 1990 under applicable laws. The company has developed a physics-based computational platform capable of accurately predicting key properties of molecules, enabling the faster discovery of high-quality, novel molecules for drug development and materials applications at lower costs. Their software is used by biopharmaceutical, industrial companies, academic institutions, and government laboratories worldwide. The company is a leading provider of computational software solutions for drug discovery. In addition to offering various software solutions to clients to accelerate molecular discovery, design, and optimization, they leverage their platform and capabilities through a series of collaborations and wholly-owned drug discovery programs covering a wide range of disease targets and indications.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin